
New Statistics Canada Data Reinforces Life Sciences as an Economic Engine
Innovative Pharmaceutical Industry Contributed $18.4 Billion to the Canadian Economy in 2022 Ottawa, May 12, 2024 – New data released […]
Put your finger on the pulse of the healthcare industry.
For media inquiries, please contact us at media@imc-mnc.ca or 613-462-5367.
Innovative Pharmaceutical Industry Contributed $18.4 Billion to the Canadian Economy in 2022 Ottawa, May 12, 2024 – New data released […]
Nominate Trailblazers in Health Equity Ottawa, May 5, 2025 – The Health Research Foundation (HRF) of Innovative Medicines Canada is […]
Ottawa, ON – Innovative Medicines Canada (IMC) congratulates Mark Carney on his election as Canada’s Prime Minister, the Liberal Party […]
Ottawa, May 26, 2025 – Innovative Medicines Canada welcomes the launch of CanReview, a pan-Canadian initiative supported by the Accelerating […]
Industry Association Applauds Commitment to the Stratégie Québécoise des sciences de la vie (2025-2028) and to Pharmaceuticals in Hospital Settings […]
Ottawa, February 3, 2025 – Innovative Medicines Canada (IMC) is pleased to welcome Patrick Hupé, M.Sc., MBA, as Vice President […]
Ensuring Pharmacare delivers fair access for all and innovation As originally published in The Hill Times Policy Briefing on May […]
This article originally appeared in Saltwire newspapers across Atlantic Canada on July 11, 2024. Dr. P.J. Devereaux, co-chair of Accelerating Clinical Trials […]
This article originally appeared in the The Globe and Mail on March 4, 2024. Strong gender representation in workplace leadership helps businesses […]
Get in touch Please complete the form below, and a representative will be in touch as soon as possible. Departments […]
At Innovative Medicines Canada, we offer sponsorship opportunities to facilitate research, generate awareness, create educational programs, and improve access to innovative medicines.
Sign up to our newsletter to get our latest news and updates.
Browse by topic
Informative content to keep you up to date on the most pressing issues facing our industry.